Schlander, Michael Prof. Dr. med. M.B.A.Universität HeidelbergHeidelberg
Publikationsliste einschränken
Publikationsjahre
Publikationstypen
Sprache
Co-Autoren (Uni Heidelberg)
Co-Autoren (extern)
- Godman, Brian (1)
- Gafni, Amiram (1)
- Adarkwah-Yiadom, Charles Christian (1)
- Annemans, Lieven (1)
- Schwarz, Oliver (1)
- Caro, J. Jaime (1)
- Eberle, Andrea (1)
- Dintsios, Charalabos-Markos (1)
- Bertram, Heike (1)
- Espin, Jaime (1)
- Parnaby, Adam (1)
- Jommi, Claudio (1)
- Hutchings, Adam (1)
- Flostrand, Steven (1)
- Borget, Isabelle (1)
- Anderson, Pippa (1)
- Waldmann, Annika (1)
- Pritzkuleit, Ron (1)
- Schmitt, Jochen (1)
- März, Julian (1)
- Deibel, Rudolf Ansgar (1)
- Wiest, Reiner (1)
- Ran, Tao (1)
- Poleszczuk, Jan (1)
- Misselwitz, Benjamin (1)
- Lang, Brian (1)
- Krupka, Niklas (1)
- Deng, Lu (1)
- Eckford, Rachel (1)
- Hernandez-Villafuerte, Karla (1)
- Zeißig, Sylke (1)
- Kolominsky-Rabas, Peter (1)
- Hernández, Diego (1)
- (weitere Einträge vorhanden...)
Publikationen in heiBIB 
- Ubels, Jasper: The use of a comprehensive concept of capability for wellbeing assessment : a best-fit framework synthesis / Jasper Ubels, Karla Hernandez-Villafuerte, Erica Niebauer, Michael Schlander, 2024. - 20 S.
In: Health care analysis, ISSN 1573-3394. (2024), Seite 1-20
DOI: 10.1007/s10728-024-00488-w
- Lwin, Min Wai: Would initiating colorectal cancer screening from age of 45 be cost-effective in Germany? : An individual-level simulation analysis / Min Wai Lwin, Chih-Yuan Cheng, Silvia Calderazzo, Christoph Schramm and Michael Schlander, 21 February 2024. - 12 S.
In: Frontiers in Public Health, ISSN 2296-2565. 12(2024), Artikel-ID 1307427, Seite 1-12
DOI: 10.3389/fpubh.2024.1307427
- Schneider, Jana: Out-of-pocket payments and loss of income among long-term breast cancer survivors in Germany : a multi-regional population-based study / Jana Schneider, Diego Hernandez, CAESAR study group, Michael Schlander, Volker Arndt, on behalf of t… , December 2023. - 21 S.
In: Journal of cancer survivorship, ISSN 1932-2267. 17(2023), 6 vom: Dez., Seite 1639-1659
DOI: 10.1007/s11764-022-01293-x
- Pham, Phu Duy: Developing a conceptual framework for socioeconomic impact research in european cancer patients : a ‘best-it’ framework synthesis / Phu Duy Pham, Michael Schlander, Rachel Eckford, Karla Hernandez-Villafuerte, Jasper Ubels, September 2023. - 22 S. : Illustrationen
In: The Patient, ISSN 1178-1661. 16(2023), 5 vom: Sept., Seite 515-536
DOI: 10.1007/s40271-023-00632-z
- Ubels, Jasper: Measurement invariance and adapted preferences : evidence for the ICECAP-A and WeRFree instruments / Jasper Ubels and Michael Schlander, 10 November 2023. - 11 S. : Illustrationen
In: Health and quality of life outcomes, ISSN 1477-7525. 21(2023), 1, Seite 1-11
DOI: 10.1186/s12955-023-02208-9
- Schlander, Michael: Nutzen der Labormedizin in der Schweiz / Michael Schlander, Ramon Schäfer, Lorenz Selberg. -
Berlin ; [Heidelberg]: Springer, [2023]. - XXIX, 303 Seiten : Diagramme, ISBN 978-3-662-66824-5
- Schlander, Michael: Nutzen der Labormedizin in der Schweiz / Michael Schlander, Ramon Schäfer, Lorenz Selberg. -
Berlin, Heidelberg: Springer Nature, 2023. - 1 Online-Ressource (303 p.), ISBN 978-3-662-66825-2
DOI: 10.1007/978-3-662-66825-2
- Schäfer, Ramon: Health technology assessment-informed decision making by the federal joint Committee/Institute for Quality and Efficiency in Health Care in Germany and the National Institute for Health and Care Excellence in England : the role of budget impact / Ramon Schaefer, Diego Hernández, Till Bärnighausen, Peter Kolominsky-Rabas, Michael Schlander, July 2023. - 13 S. : Illustrationen
In: Value in health, ISSN 1524-4733. 26(2023), 7 vom: Juli, Seite 1032-1044
DOI: 10.1016/j.jval.2023.02.018
- Hernández, Diego: Survival and comorbidities in lung cancer patients : evidence from administrative claims data in Germany / Diego Hernandez, Chih-Yuan Cheng, Karla Hernandez-Villafuerte, Michael Schlander, 31 January 2023. - 13 S.
In: Oncology research, ISSN 1555-3906. 30(2023), 4, Seite 173-185
DOI: 10.32604/or.2022.027262
- März, Julian: The ethics of COVID-19 vaccine allocation: Don't forget the trade-offs! / Julian W März, Anett Molnar, Søren Holm, Michael Schlander, 25 February 2022. - 10 S.
In: Public health ethics, ISSN 1754-9981. 15(2022), 1 vom: Apr., Seite 41-50
DOI: 10.1093/phe/phac001
- Ubels, Jasper: The value of freedom : a review of the current developments and conceptual issues in the measurement of capability / Jasper Ubels, Karla Hernandez-Villafuerte and Michael Schlander, 19 Mar 2022. - 27 S.
In: Journal of human development and capabilities, ISSN 1945-2837. 23(2022), 3, Seite 327-353
DOI: 10.1080/19452829.2022.2053506
- Muchadeyi, Muchandifunga Trust: Quality appraisal for systematic literature reviews of health state utility values : a descriptive analysis / Muchandifunga Trust Muchadeyi, Karla Hernandez-Villafuerte and Michael Schlander, 25 November 2022. - 20 S.
In: BMC medical research methodology, ISSN 1471-2288. 22(2022), Artikel-ID 303, Seite 1-20
DOI: 10.1186/s12874-022-01784-6
- Cheng, Chih-Yuan: Do certified cancer centers provide more cost-effective care? : A health economic analysis of colon cancer care in Germany using administrative data / Chih-Yuan Cheng, Thomas Datzmann, Diego Hernandez, Jochen Schmitt, Michael Schlander, 15 November 2021. - 11 S.
In: International journal of cancer, ISSN 1097-0215. 149(2021), 10 vom: Nov., Seite 1744-1754
DOI: 10.1002/ijc.33728
- Deibel, Rudolf Ansgar: Evaluating key characteristics of ideal colorectal cancer screening modalities : the microsimulation approach / Ansgar Deibel, Lu Deng, Chih-Yuan Cheng, Michael Schlander, Tao Ran, Brian Lang, Niklas Krupka, Niko… , August 2021. - 19 S.
In: Gastrointestinal endoscopy, ISSN 1097-6779. 94(2021), 2, Seite 379-390.e7
DOI: 10.1016/j.gie.2021.02.013
- Schäfer, Ramon: Is the National Institute for Health and Care Excellence (NICE) in England more ‘innovation-friendly’ than the Federal Joint Committee (G-BA) in Germany? / Ramon Schaefer & Michael Schlander, 30 Dec 2018. - 10 S.
In: Expert review of pharmacoeconomics and outcomes research, ISSN 1744-8379. 19(2019), 4, Seite 453-462
DOI: 10.1080/14737167.2019.1559732
- Espin, Jaime: Projecting pharmaceutical expenditure in EU5 to 2021 : adjusting for the impact of discounts and rebates / Jaime Espin, Michael Schlander, Brian Godman, Pippa Anderson, Jorge Mestre-Ferrandiz, Isabelle Borge… , 7 August 2018. - 15 S.
In: Applied health economics and health policy, ISSN 1179-1896. 16(2018), 6, Seite 803-817
DOI: 10.1007/s40258-018-0419-1
- Schlander, Michael: Budgetary impact and cost drivers of drugs for rare and ultrarare diseases / Michael Schlander, MD, PhD, MBA Charalabos-Markos Dintsios, PhD, RPh, MA, MPH, MSc, MHBA, Afschin Ga… , 2018. - 7 S.
In: Value in health, ISSN 1524-4733. 21(2018), 5, Seite 525-531
DOI: 10.1016/j.jval.2017.10.015
- Caro, J. Jaime: Determining value in health technology assessment : stay the course or tack away? / J. Jaime Caro, John E. Brazier, Jonathan Karnon, Peter Kolominsky-Rabas, Alistair J. McGuire, Erik N… , 2019. - 7 S.
In: PharmacoEconomics, ISSN 1179-2027. 37(2019), 3, Seite 293-299
DOI: 10.1007/s40273-018-0742-2
- Schlander, Michael: Unanswered questions / Michael Schlander, Oliver Schwarz, Götz-Erik Trott, 2017. - 1 S.
In: Deutsches Ärzteblatt international, ISSN 1866-0452. 114(2017), 25, Seite 428
DOI: 10.3238/arztebl.2017.0428a
- Annemans, Lieven: Recommendations from the European working group for value assessment and funding processes in rare diseases (ORPH-VAL) / Lieven Annemans, Ségolène Aymé, Yann Le Cam, Karen Facey, Penilla Gunther, Elena Nicod, Michele Reni… , 2017. - 15 S.
In: Orphanet journal of rare diseases, ISSN 1750-1172. 12(2017) Artikel-Nummer 50, 15 Seiten
DOI: 10.1186/s13023-017-0601-9
- Schlander, Michael: 8th European conference on rare diseases & orphan products (ECRD 2016) : meting abstracts; Edinburgh, UK, 26-28 May 2016 / Michael Schlander, Søren Holm, Erik Nord, Jeff Richardson [und 56 weitere]. -
London: BioMed Central, 2016. - 1 Online-Ressource (9 Seiten)
DOI: 10.1186/s13023-016-0515-y
- Schlander, Michael: Budget impact analysis of drugs for ultra-orphan non-oncological diseases in Europe / Michael Schlander, Charles Christian Adarkwah and Afschin Gandjour, 2015. - 10 S.
In: Expert review of pharmacoeconomics and outcomes research, ISSN 1744-8379. 15(2015), 1, Seite 171-179
DOI: 10.1586/14737167.2015.965156
- Schlander, Michael: Incremental cost per quality-adjusted life year gained? : The need for alternative methods to evaluate medical interventions for ultra-rare disorders / Michael Schlander, Silvio Garattini, Søren Holm, Peter Kolominsky-Rabas, Erik Nord, Ulf Persson, Maa… , July 2014. - 24 S.
In: Journal of Comparative Effectiveness Research, ISSN 2042-6313. 3(2014), 4, Seite 399-422
DOI: 10.2217/CER.14.34
- Gandjour, Afschin: Determining the price for pharmaceuticals in Germany : comparing a shortcut for IQWiG's efficiency frontier method with the price set by the manufacturer for ticagrelor / Afschin Gandjour, Amiram Gafni & Michael Schlander, 2014. - 7 S.
In: Expert review of pharmacoeconomics and outcomes research, ISSN 1744-8379. 14(2014), 1, Seite 123-129
DOI: 10.1586/14737167.2014.868313
- Schlander, Michael: Drug price regulation based on the principles of the social market economy : part 2 / Schlander, Michael; Jaecker, Andreas; Voelkl, Martin, 2013. - 6 S.
In: Die pharmazeutische Industrie, ISSN 0031-711X. 75(2013), 4, Seite 589-594
- Schlander, Michael: Health technology assessments (HTAs) including economic evaluation : the appraisal of treatment strategies for attention-deficit, hyperactivity disorder (ADHD) in children and adolescents by the National Institute for Health and Clinical Excellence (NICE) / vorgelegt von Michael Schlander, 2007. - XVII, 348 S. : graph. Darst.
IDs
Links
Schlander, Michael in ...
Export Publikationsliste
heiBIB
Bei fehlerhaften oder unvollständigen Angaben wenden Sie sich bitte an biblio@ub.uni-heidelberg.de.
Informationen zu heiBIB (inkl. Einbettung der Publikationslisten in eigene WWW-Seiten).
